Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000214074 | SCV000269948 | benign | not specified | 2016-04-07 | criteria provided, single submitter | clinical testing | p.Pro2062Pro in exon 32 of USH2A: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 0.6% (98/16508) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs200247886). |
Labcorp Genetics |
RCV000906976 | SCV001051647 | benign | not provided | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000906976 | SCV001832165 | benign | not provided | 2019-01-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 20507924) |
Genome- |
RCV003454565 | SCV004181693 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454564 | SCV004181694 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000906976 | SCV001919945 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000906976 | SCV001970803 | likely benign | not provided | no assertion criteria provided | clinical testing |